Entero Healthcare Solutions Limited (IN:ENTERO)
:ENTERO
ENTERO Stock Chart & Stats
₹1154.55
-₹7.15(-0.49%)
At close: 4:00 PM EST
₹1154.55
-₹7.15(-0.49%)
Day’s Range― - ―
52-Week Range₹944.00 - ₹1,509.90
Previous CloseN/A
Volume53.16K
Average Volume (3M)6.57K
Market Cap
₹51.43B
Enterprise Value₹55.05B
Total Cash (Recent Filing)₹3.49B
Total Debt (Recent Filing)₹4.43B
Price to Earnings (P/E)40.4
Beta0.83
Next Earnings
Jun 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.05
Shares Outstanding43,510,937
10 Day Avg. Volume6,792
30 Day Avg. Volume6,572
Financial Highlights & Ratios
PEG Ratio0.52
Price to Book (P/B)2.91
Price to Sales (P/S)0.99
P/FCF Ratio-54.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,350.00Price Target Upside16.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)43.77
Revenue Forecast (FY)₹83.86B
Bulls Say, Bears Say
Bulls Say
Revenue Scaling And Return To ProfitabilitySustained revenue scale and a return to net income across 2024–2025 indicate the business has moved past a growth-at-all-costs phase into operational profitability, underpinning longer-term revenue franchise strength and enabling reinvestment into distribution capabilities and commercial expansion.
Improved Balance Sheet And Lower LeverageA stronger capital base and reduced leverage enhance financial resilience, lowering refinancing risk and increasing capacity to fund working capital, capex or strategic initiatives internally; this structural improvement supports durability through industry cycles.
Asset-light Distribution And Managed-services ModelA recurring, service-oriented distribution model with logistics and tech-enabled supply-chain services creates sticky manufacturer and retailer relationships, recurring fee streams, and scale advantages that are structurally aligned with continued healthcare demand and consolidation trends.
Bears Say
Persistent Negative Operating And Free Cash FlowConsistent negative OCF and FCF mean accounting profits have not converted to cash, forcing reliance on external funding or equity; this creates durable liquidity and financing risk, limiting flexibility for investments and exposing the business to working-capital shocks.
Thin And Volatile Gross MarginsMargin volatility and recent gross margin compression reduce earnings predictability and raise vulnerability to supplier pricing, competitive pressure or cost inflation; sustaining profitability will require continual scale, mix improvement or better commercial terms.
Modest Returns On Equity Despite Equity GrowthModest ROE despite a larger equity base suggests current profitability has not yet delivered strong capital efficiency; over the medium term this limits shareholder value creation unless margins or asset turns materially improve.
Entero Healthcare Solutions Limited News
ENTERO FAQ
What was Entero Healthcare Solutions Limited’s price range in the past 12 months?
Entero Healthcare Solutions Limited lowest stock price was ₹944.00 and its highest was ₹1509.90 in the past 12 months.
What is Entero Healthcare Solutions Limited’s market cap?
Entero Healthcare Solutions Limited’s market cap is ₹51.43B.
When is Entero Healthcare Solutions Limited’s upcoming earnings report date?
Entero Healthcare Solutions Limited’s upcoming earnings report date is Jun 03, 2026 which is in 54 days.
How were Entero Healthcare Solutions Limited’s earnings last quarter?
Entero Healthcare Solutions Limited released its earnings results on Feb 12, 2026. The company reported ₹8.05 earnings per share for the quarter, missing the consensus estimate of ₹8.8 by -₹0.75.
Is Entero Healthcare Solutions Limited overvalued?
According to Wall Street analysts Entero Healthcare Solutions Limited’s price is currently Undervalued.
Does Entero Healthcare Solutions Limited pay dividends?
Entero Healthcare Solutions Limited does not currently pay dividends.
What is Entero Healthcare Solutions Limited’s EPS estimate?
Entero Healthcare Solutions Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Entero Healthcare Solutions Limited have?
Entero Healthcare Solutions Limited has 43,510,937 shares outstanding.
What happened to Entero Healthcare Solutions Limited’s price movement after its last earnings report?
Entero Healthcare Solutions Limited reported an EPS of ₹8.05 in its last earnings report, missing expectations of ₹8.8. Following the earnings report the stock price went up 0.195%.
Which hedge fund is a major shareholder of Entero Healthcare Solutions Limited?
Currently, no hedge funds are holding shares in IN:ENTERO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, nursing homes, and healthcare clinics in India. It is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. The company was incorporated in 2018 and is based in Mumbai, India.
ENTERO Stock 12 Month Forecast
Average Price Target
₹1,350.00
▲(16.93% Upside)
Technical Analysis
HealthCare Global Enterprises Ltd.
―
Medi Assist Healthcare Services Limited
―
Panacea Biotec Limited
―
Thyrocare Technologies Ltd
―
Yatharth Hospital and Trauma Care Services Limited
―